Flumequine
Flumequine is a synthetic fluoroquinolone antibiotic used primarily in veterinary medicine to treat bacterial infections. It was first introduced in the 1970s and is part of the quinolone family of antibiotics.
History[edit]
Flumequine was first synthesized in the 1970s as part of the second generation of quinolone antibiotics. It was developed as a broad-spectrum antibiotic to treat a variety of bacterial infections in animals.
Pharmacology[edit]
Flumequine works by inhibiting the DNA gyrase and topoisomerase IV enzymes, which are essential for bacterial DNA replication. By inhibiting these enzymes, flumequine prevents the bacteria from replicating and spreading, effectively treating the infection.
Veterinary Use[edit]
Flumequine is primarily used in veterinary medicine to treat bacterial infections in a variety of animals, including poultry, cattle, and fish. It is particularly effective against Gram-negative bacteria, including Escherichia coli, Salmonella, and Campylobacter.
Safety and Regulation[edit]
Due to concerns about the development of antibiotic resistance, the use of flumequine in animals that are consumed by humans is regulated in many countries. In the European Union, for example, flumequine is classified as a Category II substance, meaning it can only be used under certain conditions and with a veterinary prescription.
See Also[edit]
References[edit]
| Veterinary medicine | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
This veterinary medicine related article is a stub.
|
Sponsored Health Resource
W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
